TFA Therapeutics (RAJAF) Buildings (2020 - 2022)

TFA Therapeutics has reported Buildings for 3 years, with the latest figure at $635040.0 in Q4 2022.

• On a quarterly basis, Buildings fell 7.61% year-over-year to $635040.0 in Q4 2022; TTM through Dec 2022 was $635040.0, a 7.61% decrease from a year earlier, with the FY2022 full-year figure at $635040.0, down 7.61% from the prior year.
• Buildings was $635040.0 for Q4 2022 at TFA Therapeutics, down from $687318.0 in the prior quarter.
• The five-year high for Buildings was $687318.0 in Q4 2021, with the low at $635040.0 in Q4 2022.
• Average Buildings over 3 years is $664417.3, with a median of $670894.0 recorded in 2020.
• The sharpest annual moves came in 2021 and 2022: Buildings rose 2.45% in 2021, then decreased 7.61% in 2022.
• Over 3 years, Buildings stood at $670894.0 in 2020, then grew by 2.45% to $687318.0 in 2021, then decreased by 7.61% to $635040.0 in 2022.
• The last three Buildings figures came in at $635040.0 (Q4 2022), $687318.0 (Q4 2021), and $670894.0 (Q4 2020), per Business Quant data.